Health In Tech, Inc. (HIT) short interest & options flow
NASDAQHealth In Tech reported Q1 2026 results on May 13 after the close, and the print hands short sellers exactly the kind of validation they've been building towards — revenue came in at $4.5M, a sharp miss against the $7.3M estimate, even as the company held its full-year sales guidance at $45–50M. The short interest story has been building quietly but persistently for six weeks…
- Market cap
- $39M
- Next earnings
- 12 Nov 2026
Key data as of 12 Nov 2026

HIT news and analysis
RSSNo long-form analysis yet for HIT. Pulse alerts and the live data picture are available on ORTEX.
Open HIT on ORTEX →Want the live picture for HIT?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for HIT — free to start on ORTEX.
Sign up for free →Open HIT on ORTEX